Kozo Kuribayashi

Integrative Molecular Characterization of Malignant Pleural Mesothelioma

Julija Hmeljak, Francisco Sánchez-Vega, Katherine A. Hoadley et al. · Cancer Discovery · 2018 · 585 citations · Full text

Circulating Tumor Cell as a Diagnostic Marker in Primary Lung Cancer

Fumihiro Tanaka, Kazue Yoneda, Nobuyuki Kondo et al. · Clinical Cancer Research · 2009 · 340 citations

The Absence of Interleukin 1 Receptor–Related T1/St2 Does Not Affect T Helper Cell Type 2 Development and Its Effector Function

Katsuaki Hoshino, Shin‐ichiro Kashiwamura, Kozo Kuribayashi et al. · The Journal of Experimental Medicine · 1999 · 195 citations · Full text

Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial

Giorgio V. Scagliotti, Rabab Gaafar, Anna K. Nowak et al. · The Lancet Respiratory Medicine · 2019 · 164 citations

Placebo-controlled Phase 3, Pleural Disease, Anti-cancer Agent +6

Clinical Significance of Serum Vascular Endothelial Growth Factor in Malignant Pleural Mesothelioma

Akihiro Yasumitsu, Chiharu Tabata, Rie Tabata et al. · Journal of Thoracic Oncology · 2010 · 77 citations · Full text

Angiogenesis, Malignant Pleural Mesothelioma, Health Sciences +9